Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis

NCT02061540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Sclerosing Cholangitis (PSC)

Interventions

DRUG: LUM001

Sponsor

Mirum Pharmaceuticals, Inc.